PNVAX (PNVAX) Stock Price & Analysis
PNVAX (PNVAX) fell 0.64% to USD 48 as of September 9, 2026 at 01:19 UTC, according to Nexqual real-time market data.
PNVAX last closed at USD 48.31; the session ranged USD 48–48 on volume of 0 shares. Market capitalization is —, with a 52-week range of USD 41.29–50.46 (NAS). Source: Nexqual, September 9, 2026 at 01:19 UTC.
Key Statistics (as of September 9, 2026 at 01:19 UTC)
| Price | USD 48 |
|---|---|
| Change | ▼ 0.64% (down) |
| Previous Close | USD 48.31 |
| Open | USD 48 |
| Day Range | USD 48 – 48 |
| 52-Week Range | USD 41.29 – 50.46 |
| Volume | 0 shares |
| Market Cap | — |
| Exchange | NAS |
Technical Analysis (PNVAX)
Nexqual's technical model rates PNVAX "STRONG BUY" based on 5 bullish and 0 bearish signals across 126 daily candles, as of September 9, 2026 at 01:19 UTC.
| Overall Signal | STRONG BUY |
|---|---|
| RSI (14) | 59.83 (neutral) |
| vs SMA50 | Above (USD 46.83) |
| MACD | 0.38 (positive) |
Financial Health Score (PNVAX)
Nexqual rates PNVAX's overall financial health "Mixed" across five dimensions, as of September 9, 2026 at 01:19 UTC.
| Growth | Mixed — No data |
|---|---|
| Profitability | Mixed — No data |
| Balance Sheet | Mixed — No data |
| Cash Flow | Mixed — No data |
| Efficiency | Mixed — No data |
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| POVSX | Putnam International Equity Fd | USD 34.66 | ▼ 0.57% |
| POGAX | Putnam Growth Opportunities Fun | USD 77.88 | ▼ 0.19% |
| PNGAX | Putnam International Growth and | USD 20.07 | ▼ 0.35% |
| PHSTX | Putnam Global Health Care Fund | USD 66.06 | ▼ 3.77% |
| PEYAX | Putnam Equity Income Fund Class | USD 45.05 | ▼ 1.18% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: September 9, 2026 at 01:19 UTC. This page is informational and not investment advice.